Filing Details
- Accession Number:
- 0001170362-15-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-08 21:08:43
- Reporting Period:
- 2015-01-08
- Filing Date:
- 2015-01-08
- Accepted Time:
- 2015-01-08 21:08:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080709 | Arena Pharmaceuticals Inc | ARNA | Pharmaceutical Preparations (2834) | 232908305 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1170362 | W Steven Spector | C/O Arena Pharmaceuticals, Inc. 6154 Nancy Ridge Drive San Diego CA 92121 | Evp, General Counsel & Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-01-08 | 45,000 | $6.16 | 173,039 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-01-08 | 45,000 | $6.26 | 128,039 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-01-08 | 45,000 | $0.00 | 45,000 | $6.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2015-01-17 | No | 4 | M | Direct |
Footnotes
- The amount includes shares purchased under Arena's employee stock purchase plan prior to the reported transaction.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The options were exercisable upon grant, and vested in four equal annual installments beginning on January 17, 2006.